Viking Therapeutics (VKTX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- MongoDB stock tumbles despite earnings beat on profit-taking
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
